Latest Stocks: CVS Health Corp (CVS) Shares Sold by 1ST Source Bank

Latest Stocks: CVS Health Corp (CVS) Shares Sold by 1ST Source Bank

1ST Source Bank cut its stake in shares of CVS Health Corp (NYSE:CVS) by 5.8% during the first quarter, Holdings Channel reports. The fund owned 46,182 shares of the pharmacy operator’s stock after selling 2,841 shares during the period. 1ST Source Bank’s holdings in CVS Health Corp were worth $3,625,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. SRS Capital Advisors Inc. bought a new stake in CVS Health Corp during the fourth quarter valued at about $120,000. D Orazio & Associates Inc. raised its stake in CVS Health Corp by 34.5% in the fourth quarter. D Orazio & Associates Inc. now owns 1,560 shares of the pharmacy operator’s stock valued at $123,000 after buying an additional 400 shares during the last quarter. Elgethun Capital Management bought a new stake in CVS Health Corp during the fourth quarter valued at about $133,000. Sowell Financial Services LLC bought a new stake in CVS Health Corp during the fourth quarter valued at about $140,000. Finally, Patriot Financial Group Insurance Agency LLC bought a new stake in CVS Health Corp during the fourth quarter valued at about $156,000. 81.29% of the stock is owned by institutional investors and hedge funds.

CVS Health Corp (NYSE CVS) opened at 78.79 on Tuesday. The stock has a market capitalization of $80.27 billion, a P/E ratio of 16.43 and a beta of 0.85. The firm’s 50-day moving average price is $79.22 and its 200 day moving average price is $79.11. CVS Health Corp has a 12-month low of $69.30 and a 12-month high of $98.67.

CVS Health Corp (NYSE:CVS) last released its quarterly earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.07. CVS Health Corp had a return on equity of 10.97% and a net margin of 2.16%. The company had revenue of $44.51 billion for the quarter, compared to analysts’ expectations of $44.20 billion. During the same period in the prior year, the firm earned $1.18 earnings per share. The firm’s revenue was up 3.0% compared to the same quarter last year. On average, equities analysts anticipate that CVS Health Corp will post $5.87 EPS for the current year.

Several research firms have recently issued reports on CVS. Vetr lowered CVS Health Corp from a “strong-buy” rating to a “buy” rating and set a $85.96 price objective for the company. in a research note on Tuesday, May 23rd. Leerink Swann set a $90.00 price objective on CVS Health Corp and gave the company a “buy” rating in a research note on Saturday, February 11th. Jefferies Group LLC set a $82.00 price objective on CVS Health Corp and gave the company a “hold” rating in a research note on Saturday, April 1st. Deutsche Bank AG reaffirmed a “hold” rating and issued a $88.00 price objective on shares of CVS Health Corp in a research note on Wednesday, February 8th. Finally, Atlantic Securities lowered CVS Health Corp from an “overweight” rating to a “neutral” rating and set a $84.00 price objective for the company. in a research note on Monday, February 6th. Eight equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $94.45.

In other CVS Health Corp news, CFO David M. Denton sold 95,618 shares of the company’s stock in a transaction on Friday, March 10th. The stock was sold at an average price of $80.68, for a total transaction of $7,714,460.24. Following the transaction, the chief financial officer now directly owns 250,335 shares in the company, valued at $20,197,027.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Troyen A. Brennan sold 23,849 shares of the company’s stock in a transaction on Tuesday, March 21st. The stock was sold at an average price of $78.73, for a total value of $1,877,631.77. Following the transaction, the executive vice president now owns 94,309 shares in the company, valued at $7,424,947.57. The disclosure for this sale can be found here. Insiders have sold 139,600 shares of company stock worth $11,205,962 over the last 90 days. 0.58% of the stock is owned by insiders. CVS Health Corp Company Profile

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS). Receive News & Ratings for CVS Health Corp Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CVS Health Corp and related companies with MarketBeat.com’s FREE daily email newsletter.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Related posts

Leave a Comment